Vimta Labs is pivoting to Biologics and the China+1 opportunity. Explore its transformation from a testing lab into a research partner.
Read More
Piramal Enterprises – Awaiting a PE re-rating
Instead of a little footnote at the bottom of my post saying that i’m an interested party, I’d like to begin by saying that i’m totally interested in Piramal Enterprises and an ardent admirer of Ajay.G.Piramal. I bought into the company at Rs 360 when a back of the envelope calculation reveiled cash per share…
Read More
biginvestorblog.in 